Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Feb;71(2):329–339. doi: 10.1172/JCI110773

Characterization of a carboxyterminal peptide fragment of the human choriogonadotropin beta-subunit excreted in the urine of a woman with choriocarcinoma.

S Amr, R E Wehmann, S Birken, R E Canfield, B C Nisula
PMCID: PMC436871  PMID: 6185541

Abstract

We have observed low-molecular weight carboxyterminal fragments of the human choriogonadotropin (hCG) beta-subunit in the urines of several women with choriocarcinoma, and we have characterized one fragment in detail. Its apparent molecular weight by gel chromatography on Sephadex G-100 was 14,200. The fragment was not adsorbed to concanavalin A-Sepharose, indicating that it lacked the asparagine-linked carbohydrate groups of intact hCG beta. It was active in radioimmunoassays (RIA) using antisera either to the hCG beta carboxyterminal peptide (CTP) or to the desialylated hCG beta CTP (hCG beta as-CTP), indicating the presence of not only the hCG beta carboxyterminus but also desialylated O-serine-linked carbohydrate side chains on the fragment. It lacked luteinizing hormone/choriogonadotropin radioreceptor activity and hCG beta conformational immunoreactivity (SB6 RIA). On Sephadex G-100 gel chromatography, the elution profiles of this fragment and the hCG beta as-CTP(115-145) prepared by trypsin digestion of as-hCG were essentially indistinguishable (apparent molecular weights 14,200 and 14,000, respectively). The immunological characteristics of the fragment in both hCG beta CTP and hCG beta as-CTP RIA were indistinguishable from those of the hCG beta as-CTP(115-145) glycopeptide. Carboxyterminal fragments of hCG beta were evident in urine specimens obtained from 10 of 11 patients with choriocarcinoma but not in those obtained from normal subjects who were given an intravenous infusion of highly purified hCG. Of six pregnant women, only the one at term excreted carboxyterminal fragments of hCG beta and then only in trace amounts. We conclude that hCG beta carboxyterminal fragments, including one that is indistinguishable from the tryptic glycopeptide hCG beta as-CTP(115-145), can occur naturally in the urine of patients with choriocarcinoma.

Full text

PDF
329

Images in this article

331Image
on p.331
332Image
on p.332

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. Estimation of molecular size and molecular weights of biological compounds by gel filtration. Methods Biochem Anal. 1970;18:1–53. [PubMed] [Google Scholar]
  2. Aquino D., Wong R., Margolis R. U., Margolis R. K. Sialic acid residues inhibit proteolytic degradation of dopamine beta-hydroxylase. FEBS Lett. 1980 Apr 7;112(2):195–198. doi: 10.1016/0014-5793(80)80178-5. [DOI] [PubMed] [Google Scholar]
  3. Ashitaka Y., Nishimura R., Futamura K., Oashi M., Tojo S. Serum and chorionic tissue concentrations of human chorionic gonadotropin and its subunits during pregnancy. Endocrinol Jpn. 1974 Dec;21(6):547–550. doi: 10.1507/endocrj1954.21.547. [DOI] [PubMed] [Google Scholar]
  4. Ayala A. R., Nisula B. C., Chen H. C., Hodgen G. D., Ross G. T. Highly sensitive radioimmunoassay for chorionic gonadotropin in human urine. J Clin Endocrinol Metab. 1978 Oct;47(4):767–773. doi: 10.1210/jcem-47-4-767. [DOI] [PubMed] [Google Scholar]
  5. Baenziger J. U., Fiete D. Structural determinants of concanavalin A specificity for oligosaccharides. J Biol Chem. 1979 Apr 10;254(7):2400–2407. [PubMed] [Google Scholar]
  6. Birken S., Canfield R. E. Isolation and amino acid sequence of COOH-terminal fragments from the beta subunit of human choriogonadotropin. J Biol Chem. 1977 Aug 10;252(15):5386–5392. [PubMed] [Google Scholar]
  7. Birken S., Canfield R. E. Labeled asialo-human chorionic gonadotropin as a liver-scanning agent. J Nucl Med. 1974 Dec;15(12):1176–1178. [PubMed] [Google Scholar]
  8. Birken S., Canfield R., Agosto G., Lewis J. Preparation and characterization of an improved beta-COOH-terminal immunogen for generation of specific and sensitive antisera to human chorionic gonadotropin. Endocrinology. 1982 May;110(5):1555–1563. doi: 10.1210/endo-110-5-1555. [DOI] [PubMed] [Google Scholar]
  9. Birken S., Canfield R., Lauer R., Agosto G., Gabel M. Immunochemical determinants unique to human chorionic gonadotropin: importance of sialic acid for antisera generated to the human chorionic gonadotropin beta-subunit COOH-terminal peptide. Endocrinology. 1980 Jun;106(6):1659–1664. doi: 10.1210/endo-106-6-1659. [DOI] [PubMed] [Google Scholar]
  10. Braunstein G. D., Kamdar V., Rasor J., Swaminathan N., Wade M. E. Widespread distribution of a chorionic gonadotropin-like substance in normal human tissues. J Clin Endocrinol Metab. 1979 Dec;49(6):917–925. doi: 10.1210/jcem-49-6-917. [DOI] [PubMed] [Google Scholar]
  11. Canfield R. E., Ross G. T. A new reference preparation of human chorionic gonadotrophin and its subunits. Bull World Health Organ. 1976;54(4):463–472. [PMC free article] [PubMed] [Google Scholar]
  12. Catt K. J., Dufau M. L., Tsuruhara T. Radioligand-receptor assay of luteinizing hormone and chorionic gonadotropin. J Clin Endocrinol Metab. 1972 Jan;34(1):123–132. doi: 10.1210/jcem-34-1-123. [DOI] [PubMed] [Google Scholar]
  13. Cole L. A., Hussa R. O. Use of glycosidase digested human chorionic gonadotropin beta-subunit to explain the partial binding of ectopic glycoprotein hormones to Con A. Endocrinology. 1981 Dec;109(6):2276–2278. doi: 10.1210/endo-109-6-2276. [DOI] [PubMed] [Google Scholar]
  14. Dufau M. L., Tsuruhara T., Catt K. J. Interaction of glycoprotein hormones with agarose-concanavalin A. Biochim Biophys Acta. 1972 Sep 29;278(2):281–292. doi: 10.1016/0005-2795(72)90233-4. [DOI] [PubMed] [Google Scholar]
  15. Franchimont P., Gaspard U., Reuter A., Heynen G. Polymorphism of protein and polypeptide hormones. Clin Endocrinol (Oxf) 1972 Oct;1(4):315–336. doi: 10.1111/j.1365-2265.1972.tb00402.x. [DOI] [PubMed] [Google Scholar]
  16. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gaspard U. J., Reuter A. M., Devìlle J. L., Vrindts-Gevaert Y., Bagshawe K. D., Franchimont P. Serum concentration of human chorionic gonadotropin and its alpha and beta subunits. 2. Trophoblastic tumours. Clin Endocrinol (Oxf) 1980 Oct;13(4):319–329. doi: 10.1111/j.1365-2265.1980.tb03391.x. [DOI] [PubMed] [Google Scholar]
  18. Good A., Ramos-Uribe M., Ryan R. J., Kempers R. D. Molecular forms of human chorionic gonadotropin in serum, urine, and placental extracts. Fertil Steril. 1977 Aug;28(8):846–850. [PubMed] [Google Scholar]
  19. Hagen C., McNeilly A. S. The gonadotropic hormones and their subunits in human maternal and fetal circulation at delivery. Am J Obstet Gynecol. 1975 Apr 1;121(7):926–930. doi: 10.1016/0002-9378(75)90910-2. [DOI] [PubMed] [Google Scholar]
  20. Hammond J. M., Bridson W. E., Kohler P. O., Chrambach A. Physical characteristics of immunoreactive chorionic gonadotropin produced in culture. Endocrinology. 1971 Sep;89(3):801–806. doi: 10.1210/endo-89-3-801. [DOI] [PubMed] [Google Scholar]
  21. Hattori M., Yoshimoto Y., Matsukura S., Fujita T. Qualitative and quantitative analyses of human chorionic gonadotropin and its subunits produced by malignant tumors. Cancer. 1980 Jul 15;46(2):355–361. doi: 10.1002/1097-0142(19800715)46:2<355::aid-cncr2820460224>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  22. Kessler M. J., Mise T., Ghai R. D., Bahl O. P. Structure and location of the O-glycosidic carbohydrate units of human chorionic gonadotropin. J Biol Chem. 1979 Aug 25;254(16):7909–7914. [PubMed] [Google Scholar]
  23. Kessler M. J., Reddy M. S., Shah R. H., Bahl O. P. Structures of N-glycosidic carbohydrate units of human chorionic gonadotropin. J Biol Chem. 1979 Aug 25;254(16):7901–7908. [PubMed] [Google Scholar]
  24. Keutmann H. T., Williams R. M. Human chorionic gonadotropin. Amino acid sequence of the hormone-specific COOH-terminal region. J Biol Chem. 1977 Aug 10;252(15):5393–5397. [PubMed] [Google Scholar]
  25. Matthies D. L., Diczfalusy E. Relationships between physico-chemical, immunological and biological properties of human chorionic gonadotrophin. I. Properties of human chorionic gonadotrophin as found in tissues and body fluids. Acta Endocrinol (Copenh) 1971 Jul;67(3):434–444. doi: 10.1530/acta.0.0670434. [DOI] [PubMed] [Google Scholar]
  26. Morgan F. J., Birken S., Canfield R. E. The amino acid sequence of human chorionic gonadotropin. The alpha subunit and beta subunit. J Biol Chem. 1975 Jul 10;250(13):5247–5258. [PubMed] [Google Scholar]
  27. Nishimura R., Endo Y., Tanabe K., Ashitaka Y., Tojo S. The biochemical properties of urinary human chorionic gonadotropin from the patients with trophoblastic disease. J Endocrinol Invest. 1981 Jul-Sep;4(3):349–358. doi: 10.1007/BF03349456. [DOI] [PubMed] [Google Scholar]
  28. Nwokoro N., Chen H. C., Chrambach A. Physical, biological, and immunological characterization of highly purified urinary human chorionic gonadotropin components separated by gel electrofocusing. Endocrinology. 1981 Jan;108(1):291–299. doi: 10.1210/endo-108-1-291. [DOI] [PubMed] [Google Scholar]
  29. Papapetrou P. D., Sakarelou N. P., Braouzi H., Fessas P. Ectopic production of human chorionic gonadotropin (hCG) by neoplasms: the value of measurements of immunoreactive hCG in the urine as a screening procedure. Cancer. 1980 May 15;45(10):2583–2592. doi: 10.1002/1097-0142(19800515)45:10<2583::aid-cncr2820451018>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  30. Reuter A. M., Gaspard U. J., Deville J. L., Vrindts-Gevaert Y., Franchimont P. Serum concentrations of human chorionic gonadotrophin and its alpha and beta subunits. 1. During normal singleton and twin pregnancies. Clin Endocrinol (Oxf) 1980 Oct;13(4):305–318. doi: 10.1111/j.1365-2265.1980.tb03390.x. [DOI] [PubMed] [Google Scholar]
  31. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974 Oct;20(10):1255–1270. [PubMed] [Google Scholar]
  32. Taliadouros G. S., Amr S., Louvet J. P., Birken S., Canfield R. E., Nisula B. C. Biological and immunological characterization of crude commercial human choriogonadotropin. J Clin Endocrinol Metab. 1982 May;54(5):1002–1009. doi: 10.1210/jcem-54-5-1002. [DOI] [PubMed] [Google Scholar]
  33. Tomana M., Niedermeier W., Mestecky J., Schrohenloher R. E., Porch S. Affinity chromatography of glycopeptides using concanavalin A. Anal Biochem. 1976 May 7;72:389–399. doi: 10.1016/0003-2697(76)90546-7. [DOI] [PubMed] [Google Scholar]
  34. Tsuruhara T., Dufau M. L., Hickman J., Catt K. J. Biological properties of hCG after removal of terminal sialic acid and galactose residues. Endocrinology. 1972 Jul;91(1):296–301. doi: 10.1210/endo-91-1-296. [DOI] [PubMed] [Google Scholar]
  35. Vaitukaitis J. L., Braunstein G. D., Ross G. T. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol. 1972 Jul 15;113(6):751–758. doi: 10.1016/0002-9378(72)90553-4. [DOI] [PubMed] [Google Scholar]
  36. Vaitukaitis J. L. Immunologic and physical characterization of human chorionic gonadotropin (hCG) secreted by tumors. J Clin Endocrinol Metab. 1973 Oct;37(4):505–514. doi: 10.1210/jcem-37-4-505. [DOI] [PubMed] [Google Scholar]
  37. Wehmann R. E., Nisula B. C. Characterization of a discrete degradation product of the human chorionic gonadotropin beta-subunit in humans. J Clin Endocrinol Metab. 1980 Jul;51(1):101–105. doi: 10.1210/jcem-51-1-101. [DOI] [PubMed] [Google Scholar]
  38. Wehmann R. E., Nisula B. C. Metabolic and renal clearance rates of purified human chorionic gonadotropin. J Clin Invest. 1981 Jul;68(1):184–194. doi: 10.1172/JCI110234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wehmann R. E., Nisula B. C. Metabolic clearance rates of the subunits of human chorionic gonadotropin in man. J Clin Endocrinol Metab. 1979 May;48(5):753–759. doi: 10.1210/jcem-48-5-753. [DOI] [PubMed] [Google Scholar]
  40. Yazaki K., Yazaki C., Wakabayashi K., Igarashi M. Isoelectric heterogenity of human chorionic gonadotropin: Presence of choriocarcinoma specific components. Am J Obstet Gynecol. 1980 Sep 15;138(2):189–194. doi: 10.1016/0002-9378(80)90034-4. [DOI] [PubMed] [Google Scholar]
  41. van Hell H., Matthijsen R., Homan J. D. Studies on human chorionic gonadotrophin. I. Purification and some physico-chemical properties. Acta Endocrinol (Copenh) 1968 Sep;59(1):89–104. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES